“A careful review of all available safety data of more than 17 million people vaccinated in the European Union and UK with COVID-19 Vaccine AstraZeneca has shown no evidence of an increased risk of pulmonary embolism, deep vein thrombosis or thrombocytopenia, in any defined age group, gender, batch or in any particular country,” the statement said.
Prince Harry and Meghan Markle’s popularity plummets in U.K. post-Oprah interview
Ontario reports more than 1,700 coronavirus cases, 15 deaths
Global News has reached out to see if Health Canada was considering halting its AstraZeneca vaccine rollout or had requested any additional data from its clinical trials, but did not immediately hear back.
More to come.
— With files from Global News’ Hannah Jackson and Emerald Bensadoun
© 2021 Reuters